BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2458324)

  • 1. Anti-tumor surveillance of non-contact-inhibited transformed cell lines.
    Vanderslice WE; Collins JL
    Int J Cancer; 1988 Sep; 42(3):460-3. PubMed ID: 2458324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of contact-noninhibition in vitro and tumorigenicity in vivo.
    Collins JL; Lin Y; Patek PQ
    Cell Biol Int Rep; 1986 Oct; 10(10):789-96. PubMed ID: 2430726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 238Pu alpha-particle-induced C3H10T1/2 transformants are less tumorigenic than the X-ray-induced equivalent.
    Lehane MM; Bryant PE; Riches AC; Allen LA; Briscoe CV; Melville J; Mill AJ
    Carcinogenesis; 1999 Jan; 20(1):35-40. PubMed ID: 9934847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitransforming activity of chlorophyllin against trans-benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide].
    Ji WD; Jiang YG; Wang M; Feng SM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Sep; 37(5):335-7. PubMed ID: 14680595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of transformation and tumorigenicity in interspecies hybrids of human SV40-transformed and mouse 3T3 cell lines.
    Howell N
    Cytogenet Cell Genet; 1982; 34(3):215-29. PubMed ID: 6291863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumorigenicity and in vitro characteristics of rat liver epithelial cells and their adenovirus-transformed derivatives.
    Paraskeva C; Gallimore PH
    Int J Cancer; 1980 May; 25(5):631-9. PubMed ID: 6989767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of N-Ras gene expression using shRNA decreases transformation efficiency and tumor growth in transformed cells induced by anti-BPDE.
    Zhou L; Jiang Y; Tan A; Greenlee AR; Shen Y; Liu L; Yang Q
    Toxicol Sci; 2008 Oct; 105(2):286-94. PubMed ID: 18567617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumorigenicity of morphologically distinct transformed foci induced by 3-methylcholanthrene in BALB/c-3T3 cells.
    Keshava N
    Mutat Res; 2000 Feb; 447(2):281-6. PubMed ID: 10751612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse embryo fibroblasts transformed by activated ras or dominant-negative p53 express cross-reactive tumor rejection antigens.
    Appleman LJ; Uyeki J; Frey AB
    Int J Cancer; 1995 Jun; 61(6):887-94. PubMed ID: 7540599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local immune reaction in syngeneic mice against tumorigenic and nontumorigenic BPV-transformed mouse cell lines.
    Laatikainen A; Sarkkinen H; Syrjänen K; Mäntyjärvi R
    APMIS; 1990 Oct; 98(10):909-15. PubMed ID: 2173935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of invasive and experimental metastasis potential in BALB/c 3T3 cells by benzo(a)pyrene transformation.
    Melchiori A; Colacci A; Lollini PL; De Giovanni C; Carlone S; Grilli S; Parodi S; Albini A
    Invasion Metastasis; 1992; 12(1):1-11. PubMed ID: 1512133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of miR-506 in transformed 16HBE cells induced by anti-benzo[a]pyrene-trans-7,8-dihydrodiol-9,10-epoxide.
    Zhao Y; Liu H; Li Y; Wu J; Greenlee AR; Yang C; Jiang Y
    Toxicol Lett; 2011 Sep; 205(3):320-6. PubMed ID: 21726609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumorigenicity and lysis by natural killers.
    Collins JL; Patek PQ; Cohn M
    J Exp Med; 1981 Jan; 153(1):89-106. PubMed ID: 6161207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat embryo fibroblasts transformed by c-Jun display highly metastatic and angiogenic activities in vivo and deregulate gene expression of both angiogenic and antiangiogenic factors.
    Kraemer M; Tournaire R; Dejong V; Montreau N; Briane D; Derbin C; Binétruy B
    Cell Growth Differ; 1999 Mar; 10(3):193-200. PubMed ID: 10099833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
    Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
    Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell lines derived from tumors induced in syngeneic rats by FR 3T3 SV40 transformants no longer synthesize the early viral proteins.
    de Lapeyriere O; Hayot B; Imbert J; Courcoul M; Arnaud D; Birg F
    Virology; 1984 May; 135(1):74-86. PubMed ID: 6328754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo or in vitro selection for resistance to natural cytotoxic cell lysis selects for variants with increased tumorigenicity.
    Patek PQ; Lin Y; Collins JL; Cohn M
    J Immunol; 1986 Jan; 136(2):741-5. PubMed ID: 3941271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidine.
    Frost P; Liteplo RG; Donaghue TP; Kerbel RS
    J Exp Med; 1984 May; 159(5):1491-501. PubMed ID: 6201588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular tumorigenicity in nude mice. Role of susceptibility to natural killer cells.
    Klein AS; Plata F; Jackson MJ; Shin S
    Exp Cell Biol; 1979; 47(6):430-45. PubMed ID: 520649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment and application of oncogene over expressed human epithelial cell transformation model].
    Ma RL; Pang YQ; Li WX; Xiao YM; Wei Q; Li DC; Lai YD; Lin YC; Wang Q; Yang P; Chen LP; Tang SF; Lin ZN; Chen W
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Jun; 42(6):395-9. PubMed ID: 19035039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.